Once-daily , subcutaneous liraglutide ( @ mg ) ( n = @ ) , liraglutide ( @ mg ) ( n = @ ) , or placebo ( n = @ ) , all as adjunct to @ kcal/d dietary deficit and increased physical activity ( @ min/wk ) .